Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Jan;13(1):36–43. doi: 10.1128/iai.13.1.36-43.1976

Cell-mediated immune response to influenza virus infections in mice.

G Cambridge, J S Mackenzie, D Keast
PMCID: PMC420574  PMID: 1248876

Abstract

The local and systemic cell-mediated immune (CMI) responses to influenza virus infection in mice were examined by leukocyte migration inhibition and lymphocyte-mediated cytotoxicity tests. Mice were inoculated intranasally with 5 50% lethal doses of the A/WSN (H0N1) strain of influenza virus. Cells from the lymph nodes draining the upper and lower respiratory tract were used to measure the local response, and the spleen was the source of cells used for systemic determinations. The local response by pulmonary lymph node cells was greater and appeared earlier than was observed systemically in the spleen. The specificity of the CMI response was investigated by using a heterologous virus strain, A/Jap (H2N2), and recombinants A/Jap-NWS (H2N1) and A/NWS-Jap (H0N1), obtained from a cross between A/Jap (H2N2) and a virus, A/NWS (H0N1), with surface antigenic specificity similar to that of the inoculated virus. From the results of both tests used as correlates of CMI, it appeared that the response was specific against the hemagglutinin component of the inoculated virus. No reactivity was observed against the heterologous virus A/Jap (H2N2) nor against the recombinant A/Jap-NWS (H2N1) bearing the same neuradminidase as that of the inoculated virus.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doherty P. C., Zinkernagel R. M. T-cell-mediated immunopathology in viral infections. Transplant Rev. 1974;19(0):89–120. doi: 10.1111/j.1600-065x.1974.tb00129.x. [DOI] [PubMed] [Google Scholar]
  3. Duxbury A. E., Hampson A. W., Sievers J. G. Antibody response in humans to deoxycholate-treated influenza virus vaccine. J Immunol. 1968 Jul;101(1):62–67. [PubMed] [Google Scholar]
  4. FAZEKAS DE ST GROTH S., WHITE D. O. An improved assay for the infectivity of in influenza viruses. J Hyg (Lond) 1958 Mar;56(1):151–162. doi: 10.1017/s0022172400037621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Feinstone S. M., Beachey E. H., Rytel M. W. Induction of delayed hypersensitivity to influenza and mumps viruses in mice. J Immunol. 1969 Oct;103(4):844–849. [PubMed] [Google Scholar]
  6. Fimmel P. J., Keast D. Studies on in vitro leucocyte migration inhibition. Aust J Exp Biol Med Sci. 1974 Oct;52(5):745–753. doi: 10.1038/icb.1974.74. [DOI] [PubMed] [Google Scholar]
  7. Gadol N., Johnson J. E., 3rd, Waldman R. H. Respiratory tract cell-mediated immunity: comparison of primary and secondary response. Infect Immun. 1974 May;9(5):858–862. doi: 10.1128/iai.9.5.858-862.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gardner I., Bowern N. A., Blanden R. V. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms. Eur J Immunol. 1974 Feb;4(2):68–72. doi: 10.1002/eji.1830040203. [DOI] [PubMed] [Google Scholar]
  9. Habershon R. B., Molyneux M. E., Slavin G., Loewi G., Tyrrell D. A. Skin tests with influenza virus. J Hyg (Lond) 1973 Dec;71(4):755–760. doi: 10.1017/s0022172400023019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henney C. S., Waldman R. H. Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science. 1970 Aug 14;169(3946):696–697. doi: 10.1126/science.169.3946.696. [DOI] [PubMed] [Google Scholar]
  11. Labowskie R., Edelman R., Rustigian R., Bellanti J. A. Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis. 1974 Mar;129(3):233–239. doi: 10.1093/infdis/129.3.233. [DOI] [PubMed] [Google Scholar]
  12. Perkins J. C., Tucker D. N., Knope H. L., Wenzel R. P., Hornick R. B., Kapikian A. Z., Chanock R. M. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol. 1969 Oct;90(4):319–326. doi: 10.1093/oxfordjournals.aje.a121076. [DOI] [PubMed] [Google Scholar]
  13. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  14. Ruben F. L., Jackson G. G., Gotoff S. P. Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun. 1973 Apr;7(4):594–596. doi: 10.1128/iai.7.4.594-596.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Smith C. B., Bellanti J. A., Chanock R. M. Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines. J Immunol. 1967 Jul;99(1):133–141. [PubMed] [Google Scholar]
  16. Svejcar J., Johanovský J., Pekárek J. Studies on the mechanism of delayed type hypersensitivity in tissue cultures. V. The influence of the specific antigen concentration upon the spleen cell migration in normal and sensitized guinea-pigs. Z Immunitatsforsch Allerg Klin Immunol. 1966 Oct;131(4):301–327. [PubMed] [Google Scholar]
  17. Waldman R. H., Henney C. S. Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization. J Exp Med. 1971 Aug 1;134(2):482–494. doi: 10.1084/jem.134.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Waldman R. H., Spencer C. S., Johnson J. E., 3rd Respiratory and systemic cellular and humoral immune responses to influenza virus vaccine administered parenterally or by nose drops. Cell Immunol. 1972 Feb;3(2):294–300. doi: 10.1016/0008-8749(72)90168-2. [DOI] [PubMed] [Google Scholar]
  19. Webster R. G., Laver W. G. Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. J Immunol. 1966 Apr;96(4):596–605. [PubMed] [Google Scholar]
  20. Weisbart R. H., Bluestone R., Goldberg L. S., Pearson C. M. Migration enhancement factor: a new lymphokine. Proc Natl Acad Sci U S A. 1974 Mar;71(3):875–879. doi: 10.1073/pnas.71.3.875. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES